Switch to:
More From Other Websites
Lucky 7: These Stock Market Leaders Have Top Dividend Growth Rates Aug 28 2015
Swiss Miss: Switzerland Skirts Recession, But ETFs Struggle Aug 28 2015
Research and Markets: Investigation Report on China's Ranibizumab Market, 2012-2019 Aug 28 2015
Things could get pricey if you wear contacts Aug 27 2015
Novartis International BioCamp highlights how collaboration and diversity drive innovation and... Aug 27 2015
Contact lens makers see their day in court Aug 27 2015
Novartis' (NVS) Promacta Label Further Expanded in U.S. Aug 26 2015
Glaxo in $1 Billion Ofatumumab Deal With Novartis Aug 26 2015
FDA Grants Expanded Use of Promacta for Novartis Aug 24 2015
Novartis could pay more than $1B for GlaxoSmithKline MS drug Aug 21 2015
Novartis could pay more than $1B for GlaxoSmithKline MS drug Aug 21 2015
Novartis' Odomzo Gets European Approval for Skin Cancer Aug 21 2015
GSK sells cancer and multiple sclerosis drug to Novartis in $1bn deal Aug 21 2015
European stocks plunge on China, Greece worries Aug 21 2015
Novartis buys remaining rights to GSK treatment for up to $1 bln Aug 21 2015
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other... Aug 21 2015
GSK to divest ofatumumab for auto-immune indications to Novartis for up to $1 billion plus royalties Aug 21 2015
Novartis to Acquire Rights to Glaxo MS Drug for Up to $1 Billion Aug 21 2015
How companies can enrich shareholders—and the planet Aug 20 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK